Head-to-head · WeighScore
BodyLogicMD vs Roboclinic
The verdict
Roboclinic takes it — 65/100 to 63.1/100, but only just.
Roboclinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care. BodyLogicMD is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BodyLogicMD | Roboclinic |
|---|---|---|
| WeighScore | 63.1/100 | 65/100 |
| Grade | C | C |
| Scorecard rank | #263 | #234 |
| Semaglutide | Not disclosed | $179/mo (12-month plan, compounded) |
| Tirzepatide | Not disclosed | $299/mo (12-month plan, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #263 · C
Strengths
- Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
- Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
- Transparent $79/month membership, no insurance required, cancel anytime
Where it loses points
- GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
- Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
- State availability and dispensing pharmacy are not disclosed on the marketing site
Graded #234 · C
Strengths
- Compounded semaglutide from $179/mo and tirzepatide from $299/mo on 12-month plans
- One all-in price bundles the provider consult, prescription, and delivery
- Offers both injectable and oral (tablet) compounded semaglutide
- 'Same price, every dose' means your cost does not rise as the dose increases
- AI-first intake with board-certified provider review; no insurance necessary
Where it loses points
- Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)
- Individual compounding pharmacies are not named; fulfillment is routed through OpenLoop Health
- No published per-state list; site claims 'all 50 states, restrictions apply' and gates doctor review by region
- Refunds limited to your most recent billing cycle; none for used or partially used periods
- Operated by BrickFi, Inc., a newer brand with limited independent track record
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.